[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 29, 1906

Somnos.

JAMA. 1906;XLVII(13):1033-1036. doi:10.1001/jama.1906.02520130057013

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

We give space to the following letter so that the H. K. Mulford Company cannot say that we are not treating it fairly, although much of the letter is a repetition of what has been stated before. There is no use in attempting to befog the question:

Philadelphia, Sept. 19, 1906.

To the Editor:  —Had your report of the findings on "Somnos" (Elixir Trichlorethidene Propenyl Ether, Mulford) been confined to that product, we might not have felt called on to address this letter of protest, even though prejudice is shown in the treatment of the subject.You have seen fit, in The Journal of the American Medical Association, September 15, to attack the integrity of the H. K. Mulford Company and seriously to injure our reputation as a manufacturing house. To this we take strong exception. As your charges are based on what we have said on labels and in

First Page Preview View Large
First page PDF preview
First page PDF preview
×